TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

MoonLake Immunotherapeutics Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights – MLTX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Levi & Korsinsky, Llp
MoonLake Immunotherapeutics Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights – MLTX

MoonLake Immunotherapeutics faces a class action lawsuit alleging securities fraud related to misleading statements about its drug candidate SLK's potential clinical benefits and molecular structure.

Insights
CMCSA   neutral

Mentioned as a streaming competitor, but no specific performance details provided


MLTX   negative

The company is being sued for allegedly making false statements about its drug candidate's capabilities, suggesting potential misrepresentation of scientific claims and potential damage to investor confidence